WEBULL
WebtradeDownload

Oscar Health (OSCR) Draws Undervalued Calls, Is The Huge Fair Value Gap Credible?

Simply Wall St · 2d ago

Oscar Health (OSCR) has recently drawn fresh attention after a move in its share price, with the stock closing at $32.91 on 7 October 2026. Investors are reassessing what the latest trading action implies.

The latest move comes on top of a strong run, with a 1-day share price return of 1.76% and a 7-day gain of 6.71%, contributing to a year-to-date share price return of 119.84% and a 1-year total shareholder return of 50.96% for Oscar Health.

Scan how Oscar Health fits into the broader move in healthcare by comparing it with hand-picked 34 healthcare AI stocks that are also catching fresh pricing momentum.

Oscar Health now trades modestly below the average analyst target of $35.40 after this sharp run. Is that discount a genuine margin of safety, or a hint that the market’s caution is well placed?

Most Popular Narrative: 94% Undervalued

Compared with the last close at $32.91, the most followed narrative on Oscar Health points to an implied fair value of $583.34. This frames the recent share price move as small next to the valuation gap some investors see.

Every so often, a ticker flashes on my screen that makes me stop and rub my eyes. It is the kind of number that looks like a mistake, like you thought you were getting clothes on Christmas Day, but then your parents surprise you by hiding the PlayStation 2 you've been wanting for months in the other room...

The screen showed Oscar Health. Ridiculous name for a health insurance company, but the numbers are anything but.

See why 11 investors see Oscar Health as 94% undervalued.

Result: Fair Value of $583.34 (UNDERVALUED)

Still, the Oscar Health story can break if the high-growth assumptions in that DCF model prove too optimistic or if cash generation weakens relative to those expectations.

Find out about the key risks to this Oscar Health narrative.

Next Steps

Sentiment around Oscar Health is split, with strong upside narratives on one side and pointed concerns on the other. Move quickly, study the numbers, then weigh both angles through the 2 key rewards and 2 important warning signs.

Looking for more investment ideas beyond Oscar Health?

Do not stop your research with Oscar Health when a broader set of opportunities could fit your style, risk appetite, and income goals just as well.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.